Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Wednesday, September 24, 2014

BrainStorm Receives Approval for Uplisting to the NASDAQ Capital Market

Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwna technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University.

http://ift.tt/1rbgwgl

No comments:

Post a Comment

Popular Stem Cell Roundup Posts